Soluble 60 kDa heat shock protein (HSP60) activates macrophages via TLR4. We now report that soluble HSP60 activates T cells via the innate receptor TLR2. HSP60 activated T cell adhesion to fibronectin to a degree similar to other activators: IL-2, SDF-1α, and RANTES. T cell type and state of activation was important; nonactivated CD45RA + and IL-2-activated CD45RO + T cells responded optimally (1 h) at low concentrations (0.1-1 ng/ml), but nonactivated CD45RO + T cells required higher concentrations (~1 µg/ml) of HSP60. T cell HSP60 signaling was inhibited specifically by monoclonal antibodies (mAb) to TLR2 but not by a mAb to TLR4. Indeed, T cells from mice with mutated TLR4 could still respond to HSP60, whereas Chinese hamster T cells with mutated TLR2 did not respond. The human T cell response to soluble HSP60 depended on phosphatidylinositol 3-kinase and protein kinase C signaling and involved the phosphorylation of Pyk-2. Soluble HSP60 also inhibited actin polymerization and T cell chemotaxis through extracellular matrix-like gels toward the chemokines SDF-1α (CXCL12) or ELC (CCL19). Exposure to HSP60 for longer times (18 h) down-regulated chemokine receptor expression: CXCR4 and CCR7. These results suggest that soluble HSP60, through TLR2-dependent interactions, can regulate T cell behavior in inflammation.
T cells were purified from healthy human donor peripheral blood. The cells were isolated on Ficoll-Histopaque prepacked columns and washed. B cells and monocytes were depleted as described previously (22) . Next, CD3 + T cells were isolated by negative selection with a mouse anti-human antibody cocktail (Pan T cell kit; Miltenyi Biotec; Germany) containing mAb against CD11b, CD16, CD19, CD36, and CD56. The labeled cells were then passed through separation columns (MidiMACS columns, Miltenyi Biotec). In a second round of purification, CD3 + T cells were labeled for negative selection with magnetically coupled mAb against CD45RA + and CD45RO + (Miltenyi Biotec). The purified cells obtained (usually >97% CD45RO + or CD45RA + T cells) were cultured in RPMI containing antibiotics and 10% heat-inactivated FCS.
Mouse and Chinese hamster thymocytes
Cells were obtained from the thymuses of C3HeB/FeJ and C3H/HeJ mice or Chinese hamsters (females, 6 wk old). After the preparation of single cell suspensions, the cells were untreated or treated with HSP60 as described.
T cell adhesion and migration assays.
Analysis of T cell adhesion to ECM components was determined as described previously (22) . Briefly, flat-bottom microtiter well plates were precoated with FN, laminin, or collagen type I (10 µg/ml), and the remaining binding sites were blocked with 1% BSA. Next, 51 Cr-labeled T cells were resuspended in RPMI medium supplemented with 1% HEPES buffer and 0.1% BSA (adhesion medium), preincubated (30 min, 37°C, 7% CO 2 in a humidified atmosphere) with HSP60, GroEL MT-HSP65, or LPS, and the cells were then added to the wells. The plates containing the test materials were further incubated (30 min, 37°C in a 7% CO 2 humidified atmosphere) and then gently washed. The adherent cells were lysed (1 M NaOH, 0.1% Triton X-100 in H 2 O), removed, and counted using a γ-counter (Packard, Downers Grove, IL). The results are expressed as the mean (±SD) percentage of bound T cells from quadruplicate wells. Migration assays of CD45RA + and CD45RO + T cell chemotaxis was performed and analyzed as described within ECM-like gels, containing collagen type I, FN, and laminin (23) .
Western blot analysis of T cell lysates
Human CD45RA + or CD45RO + T cells were incubated in starvation medium (RPMI medium without serum) for 24 h (23). Before testing, 5 x 10 6 cells per sample were activated with different concentrations of HSP60 (15 min, 37°C in a 7% CO 2 humidified atmosphere). Freezing the plates at -70°C for 10 min terminated the reaction. The thawed cells were incubated (60 min, 4°C) in lysis buffer containing EDTA (0.5 mM), NaCl (150 mM), NaF (10 nM), Tris pH 7.5 (25 mM), Triton X-100 (1%), PMSF (200 µg/ml), and phosphatase inhibitor cocktail (1%; Sigma), cleared by centrifugation (30 min, 14x10 3 rpm), and the supernatants were analyzed for protein content. Sample buffer was then added, and, after boiling, the samples, containing equal amounts of proteins, were separated on 10% SDS-PAGE gel and transferred to nitrocellulose membranes. The membranes were blocked [TBST buffer containing low-fat milk (5%), Tris pH 7.5 (20 mM), NaCl (135 mM), and Tween 20 (0.1%)] and probed with the following antibodies: antiphosphorylated Pyk2 (pPyk2) and anti-total Pyk2 (tPyk2): 1.5 and 0.2 µg/ml, respectively. For TLR2 and TLR4 analysis in T cell lysates, 30 µg of protein from each sample were loaded on 10% SDS-PAGE gel and transferred to nitrocellulose membranes. The membranes were blocked and probed with mAbs against TLR2 and TLR4 (500 µg/ml). Immunoreactive protein bands were visualized using horseradish peroxidase-conjugated secondary Ab and the enhanced ECL system.
Actin polymerization.

CD45RA
+ T cells (3x10 6 cells/ml) were preincubated with HSP60 (1 h, 37°C in a 7.5% CO 2 humidified atmosphere) and treated with 200 ng/ml of SDF-1α for 15 s at 37°C and then fixed by the addition of a threefold volume of 3.7% PFA for 10 min at 22°C. Next, the cells were extensively washed, the membranes were permeabilized, and the T cells were stained with FITCphalloidin (2 µg/ml), washed, and analyzed by FACScan at 525 nm, using Cell Quest Software, as we described previously (23) .
Flow cytometry
Purified human T cells (10 6 cells/sample) were stained (30 min, 4°C) with mouse mAb antihuman LFA-1, CXCR4, CCR5, and L-selectin (20 µg/ml each); washed with PBS (containing 0.05% BSA and 0.05% sodium azide); and incubated (30 min, 4°C) with an FITC-conjugated goat anti-mouse IgG (Jackson ImmunoResearch Lab. Inc., West Grove, PA). After being washed, T cell staining was analyzed using a Becton Dickinson FACSort (Mountain View, CA) using the Cell Quest software.
RESULTS
HSP60 induces T cell adhesion to FN
We purified T cells from the peripheral blood of healthy human donors, fractioned the T cells into CD45RA
+ and CD45RO + subpopulations, incubated the T cells with various concentrations of human HSP60 for various times, and assayed adhesion of the T cells to immobilized ECM components: FN, laminin, or type 1 collagen. We found that HSP60 did not affect cell viability but enhanced T cell adhesion specifically to FN; there was little or no effect on T cell adherence to laminin or collagen type 1 (not shown). The adhesion experiments presented here use, therefore, immobilized FN as the ECM substrate. Figure 1A shows the effects of various concentrations of human HSP60 on T cell adhesion to FN, measured as the percentage of T cells adhering to FN (background adhesion: 10±3%). It can be seen that the nonactivated CD45RA + population responded to relatively low concentrations of HSP60 (0.1-1.0 ng/ml). Adhesion decreased at concentrations of 10-100 ng/ml and then increased again at concentrations of 1000-5000 ng/ml. The nonactivated CD45RO + population responded mostly to the higher concentrations (>100 ng/ml) of HSP60.
CD45RO
+ T cells include memory T cells that are responsive to activation by IL-2; we therefore tested whether preactivation with IL-2 might influence the response of the CD45RO + T cells. Figure 1A shows that activation by IL-2 increased the sensitivity to HSP60 of the CD45RO + T cell population by 1000 fold. Thus the state of a T cell can influence the way it responds to different concentrations of HSP60.
Time-course experiments demonstrated that 1 h of treatment with HSP60 (30 min pretreatment with HSP60 plus 30 min of incubation on FN) induced peak levels of adhesion (Fig. 1B) . Therefore, we used this incubation, unless indicated otherwise. Figure 1C compares the degree of CD45RA + T cell adhesion induced by 1 ng/ml HSP60 compared with previously known inducers of T cell adhesion in the 1 h assay. It can be seen that HSP60 was as effective as were optimal concentrations of the pro-inflammatory chemokines SDF-1α (100 ng/ml) or RANTES (100 ng/ml) or the cytokine IL-2 (100 IU/ml). PMA (50 ng/ml) was more effective than these physiological protein molecules, and the control recombinant molecules VEGF or βFGF (both at 100 ng/ml) were no more effective than the background. Thus HSP60 seems to induce T cell adhesion to FN to about the same degree as do other physiological signals for T cell adhesion.
HSP60 mediates adhesion via a TLR2 pathway
HSP60 has been found to activate macrophages and other cells via TLR4 or TLR2 (17) . T cells, however, have been reported to express TLR2 but not TLR4 (19) . Figure 2A shows that we could detect both TRL4 and TLR2 proteins in unseparated peripheral blood mononuclear cells (PBMC), but purified T cells were much richer in TLR2 than in TLR4.
To test whether TLR2 or TLR4 might be functionally involved in the activation of T cell adhesion by HSP60, we assayed the effect of preincubating CD45RA + T cells with blocking antibodies to the TLR molecules. Figure 2B shows that T cell adhesion to FN induced by HSP60 was inhibited by an antibody to TLR2 but not by an antibody to TLR4. This suggested that TLR2 and not TLR4 might be important for HSP60-induced adhesion.
We also tested the effect of HSP60 on the activation of adherence to FN of thymocytes taken from experimental animals with mutations in TLR molecules. Mice of the C3H/HeJ strain harbor a point mutation in TLR4, rendering it nonfunctional, whereas the related C3HeB/FeJ strain has an intact TLR4 molecule (24) . It has been reported that Chinese hamsters carry a frameshift mutation in TLR2 resulting in a protein without transmembrane and intracellular domains (25) . We isolated thymocytes from 6-wk-old Chinese hamsters and tested their ability to adhere to FN in response to various stimuli. Figure 2C shows that these cells did not adhere to FN in response to recombinant HSP60, but we found that they responded normally to PMA and ConA (data not shown). These results are compatible with the conclusion that TLR2, and not TLR4, is important for T cell adhesion to FN induced by HSP60.
Finally, Fig. 2D shows that the anti-TLR2 antibody inhibited specifically HSP60-induced adherence to FN of purified human CD45RA + T cells but not adherence induced by SDF-1α or IL-2. Thus the anti-TLR2 antibody was specific for HSP60-induced adherence.
HS60-induced adhesion is not due to contaminating LPS
LPS is known to activate cells via both TLR4 and TLR2 (1, 17, 18) . It was therefore critical to learn whether contamination of the recombinant HSP60 by LPS might have been responsible for the activation of T cell adhesion in our experiments. Figure 3A shows the amounts of LPS detected in the recombinant HSP60 preparations we used. It can be seen that 1.161 EU/ml of LPS could be detected in GroEL but that LPS was essentially undetectable in the other two preparations: human HSP60 and MT-HSP65 (i.e., <0.1 pg/ml).
We also tested the dose-response curves of CD45RA+ and CD45RO+ human T cells to purified LPS itself. Figure 3B shows the effect on T cell adhesion to FN of various concentrations of LPS. The undulating form of the LPS dose-response curve and the greater sensitivity of the CD45RA+ T cells were similar to what was observed in response to human HSP60. Note, however, that a 1000-fold greater concentration of LPS was needed and the maximal adhesion response was still less than that induced by human HSP60 (compare Figs. 1A and 3B). Thus, LPS contamination of the HSP60 was not likely to account for the induction of T cell adhesion.
To discriminate between HSP60 and LPS in yet another way, we tested the effects of mAb anti-HSP60 antibody, boiling (that denatures HSP60 but not LPS), or the LPS inhibitor polymyxin B (PMB; ref 17) on both preparations. Figure 3C shows that the effect of HSP60 on T cell adhesion was inhibited by boiling but not by PMB; the opposite was noted with LPS. We also found that mAb anti-human HSP60 specifically inhibited the proadhesive effect of HSP60 but not LPS. Taken together, the results shown in Fig. 3A , B, and C lead to the conclusion that the effect of HSP60 in activating T cell adhesion could not be explained by LPS contaminating the HSP60 preparation. Figure 4A shows the response to low concentrations of the HSP60 molecule of E. coli (GroEL). It can be seen that GroEL also enhanced the adhesion of the CD45RA + population, but to a lesser degree than the adhesion induced by human HSP60 (compare Figs. 1A and 4A). However, not all species of HSP60 appear able to activate adhesion of CD45RA + T cells at nanograms per milliliter concentrations; the HSP60 molecule of MT-HSP65 was not active in this assay (Fig.  4B ). These findings support the conclusion that mammalian HSP60 can be more effective on T cells than some closely related (1) prokaryotic HSP60 family molecules.
GroEL but not MT-HSP65 induces T cell adhesion
HSP60-induced T cell adhesion depends on β1 integrins
Information about molecular mechanisms involved in the T cell response to HSP60 is shown in Fig. 5 . Figure 5A shows that HSP60-induced adhesion was significantly inhibited by monoclonal antibodies to VLA4, VLA5 (the FN-specific α4 and α5 chains of β1 integrins), or CD29 (the common β1 integrin chain); in contrast, control monoclonal antibodies to VLA2 (α2β1), VLA3 (α3β1), or CD44 did not affect HSP60-induced adhesion. It is noteworthy that 1 h treatment of the two T cell subpopulations with HSP60 did not affect the expression levels of FN-specific α4β1 and α5β1 integrins (data not shown). Thus, existing FN-specific β1 integrins on T cells would appear to be activated in HSP60-induced adhesion. This adhesion appears to involve phosphatidylinositol 3-kinase (PI-3 kinase) and protein kinase C (PKC) signaling because it was inhibited (Fig. 5B) by the compounds wortmanin and GF109203X (GF) but not by pertussis toxin (PTX), which inhibits specifically G-protein-coupled signaling (19) .
The cytoplasmic tyrosine kinase 2 (Pyk-2) is a member of the focal adhesion kinase (FAK) family of molecules that are phosphorylated upon PKC activation (26) (27) (28) . Tyrosine phosphorylation of Pyk2 (and related molecules) increases the activity of this kinase and links β1 integrins to multiple signaling pathways regulating adhesion and migration processes in T lymphocytes. Such intracellular processes are also involved in the regulation of mitogenactivated protein (MAP) kinases (such as ERK-2) and Jun-NH 2 kinase pathways (29) (30) (31) . Figure  5C shows that a short treatment (15 min) of nonactivated CD45RA + T cells with HSP60 (0.01-100 ng/ml) induced the phosphorylation of Pyk-2. Note that similar to T cell adhesion to FN (see Fig. 1A ), Pyk-2 phosphorylation showed a bell-shaped dose-response to rising concentrations of HSP60, reaching peak phosphorylation at 1 ng/ml HSP60. Thus, Pyk-2 phosphorylation accompanies the response of T cells to effective concentrations of HSP60.
HSP60 inhibits chemokine-induced T cell chemotaxis and actin polymerization
The ability of T cells to navigate through the ECM depends on combined signals mediated by proadhesive mediators like cytokines and chemoattractants, associated with ECM glycoproteins. With the use of a three-dimensional, ECM-like gel system designed to follow in real time the migration of individual leukocytes along chemotactic gradients in vitro, we have found that IL-2, RANTES, or SDF-1α gradients can activate human CD4 + T cell chemotaxis along the ECM (23). We found that HSP60 alone, presented into the chemokine zone (drop III) at the beginning of the assay, did not activate CD45RA + T cell chemotaxis (not shown), although it did induce adhesion (see Fig. 1A ). We then tested the effect of HSP60 treatment on T cell chemotaxis. Untreated or HSP60-treated CD45RA + T cells were embedded in ECM gels, onto which a chemokine depot (SDF-1α or ELC, Fig. 6A and B, respectively) was previously introduced, and the directional migration of the cells was monitored over time as described previously (28) . Figure 6A shows that ~30% of untreated CD45RA + T cells moved toward the SDF-1α source; there was no directional movement in the absence of SDF-1α (P<0.05). Treatment of the human T cells with a concentration of 0.1 ng/ml of HSP60, however, inhibited 66% of the T cells migrating toward SDF-1α (P<0.01). Thus, a concentration of HSP60 that induces adhesion also inhibits T cell migration toward SDF-1α within an ECM-like gel.
CD45RA+ T cells have also been shown to respond to the chemokine ELC (also designated CCL19), a prototypic lymph node chemokine that attracts migrating dendritic cells and CD45RA+ T cells to T cell areas within the lymph node (30) . Figure 6B shows that HSP60, at 0.1 ng/ml, also significantly inhibited (60% inhibition at t=30 min; P<0.05) the migration of T cells toward ELC. Thus, HSP60 induced inhibition of ECM chemotaxis to both SDF-1α and ELC.
T cell adhesion to and migration through immobilized ECM ligands requires actin polymerization and subsequent cellular polarization (21, 30) . To study actin polymerization, CD45RA + T cells were left intact or treated with HSP60 (1 h, 1 ng/ml) and then activated by SDF-1α (100 ng/ml) for 15 s. The proportion of redistributed F-actin in untreated control T cells was considered to be 100%. Figure 6C shows that HSP60 inhibited actin polymerization triggered by SDF-1α. Moreover, this inhibitory effect of HSP60 was itself inhibited by an anti-TLR2 mAb but significantly less so by the isotype-matched anti-TLR4 monoclonal antibody. Hence, the effect of HSP60 on the rearrangement of the cytoskeleton and its associated signaling molecules (32) also involves TLR2 signaling.
HSP60 inhibits CXCR4 and CCR7 expression
The inhibition of T cell migration to SDF-1α and ELC (Fig. 6 ) raised the question of the effect of HSP60 on the expression of chemokine receptors: CXCR4, which is involved in T cell chemotaxis toward SDF-1α (CXCL12, and CCR7, which is involved in immune cell chemotaxis toward CCL19 (ELC). Accordingly, we incubated human T cells with various concentrations of HSP60 and assayed the expression of the chemokine receptors CXCR4 and CCR7 at various times. We found that 18 h of incubation sufficed to reduce specifically the expression of these receptors. Figure 7A and C, shows that 0.1 ng/ml of HSP60 down-regulated the expression of CXCR4 and CCR7 by 40-50% in CD5RA + T cells. Inhibition of CXCR4 in CD45RO + T cells required higher concentrations of HSP60 (1 µg/ml; Fig. 7B ). Similar HSP60 treatment of CD45RA + T cells did not affect the expression of LFA-1 or of L-selectin (Fig. 7D) . Figure 7E shows that this downregulation of expression of CXCR4 on CD5RA + T cells by HSP60 was blocked by anti-TLR2 but not by anti-TLR4 mAb. The inhibitor of PKC signaling, GF109203X, also inhibited the effect of HSP60 on CXCR4 expression (not shown). Thus, the regulatory effect of HSP60 on CXCR4 also requires TLR2 and PKC signaling.
DISCUSSION
The results presented here show that soluble HSP60 can induce activation of β1 integrins in human T cells and enhance human T cell adhesion specifically to the FN component of the ECM. Associated intra-cellular events included activation of signal molecules, PI-3 kinase and PKC, and the subsequent phosphorylation of Pyk-2, a cytoskeletal molecule associated with β1 integrin activation. HSP60 activated a degree of adhesion similar to that activated by other molecules previously known to augment T cell adhesion, such as the chemokines SDF-1α and RANTES and the cytokine IL-2. Incubation of T cells with soluble HSP60 also inhibited SDF-1α-induced cytoskeletal rearrangement (actin polymerization) and SDF-1α and ELC (CCL19)-induced chemotaxis in ECM-like gels. The expression of the relevant chemokine receptors, CXCR4 and CCR7, was also inhibited by HSP60 treatment. It remains to be learned why the effect of HSP60 in inhibiting T cell chemokine receptor (CXCR4 and CCR7) expression required more time than did blocking of chemotaxis and enhancement of adhesion (18 h compared with 1 h). Nevertheless, both types of effects were inhibited by a specific mAb to TLR2 but not by a mAb anti-TLR4. Thus, the effects of HSP60 on T cells would seem to be TLR2 dependent.
Although bacterial HSP60 molecules are quite similar in sequence and structure to mammalian HSP60 molecules (33) , the GroEL molecule of E. coli was less potent for human T cells than was human HSP60, and MT-HSP65 was ineffective in inducing adhesion. Apparently, the innate T cell receptor can be more sensitive to self-HSP60 than to foreign HSP60. It is also noteworthy that the T cells were much more sensitive to HSP60 than they were to LPS (Fig. 3B) . Moreover, the effect of HSP60 was inhibited by a mAb specific for HSP60 and was sensitive to temperature but not to PMB; the opposite was observed with LPS (Fig. 3C ). These findings, taken together, argue against the possibility that the effects of HSP60 we observed on T cells might have been induced by LPS contamination.
It is interesting that the sensitivity of the T cell response to HSP60 was influenced by T cell subset and state of activation. CD45RA + T cells responded to lower concentrations of HSP60 than did CD45RO + T cells. However, the CD45RO + T cells gained enhanced sensitivity after activation by IL-2. Indeed, exposure to IL-2 was reported to induce an enhanced expression of TLR2 mRNA in murine T cells (34) .
The complex physiology of the innate response to soluble HSP60 is also highlighted by the 1000-fold greater sensitivity of T cells compared with macrophages. The innate receptor TLR4 appears to be required for the macrophage response to HSP60 (35) (36) (37) (38) . As we show here, murine T cells with nonfunctional, mutated TLR4 could still respond to HSP60, indicating that TLR4 is not required for this innate T cell response. Indeed, antibody to the innate TLR2 molecule inhibited the T cell responses to soluble HSP60. This implies that the innate T cell response to HSP60 requires TLR2 signaling. The Chinese hamster was reported to harbor a frameshift mutation leading to a nonfunctional TLR2 molecule (25); we found that agents such as PMA can activate the adhesion of Chinese hamster thymocytes to FN (Fig. 2C) . However, HSP60 is ineffective. This further implies that an intact, functional TLR2 is required for HSP60 signaling in T cells. It remains to be seen whether TLR2 serves as a primary receptor for soluble HSP60 or whether TLR2 is a necessary participant in the response of other receptors to the HSP60 molecule.
The bi-phasic, low, and high dose-response curve of T cell reactivity to HSP60 (Fig. 1A) raises the possibility that the HSP60 molecule might be recognized by multiple receptors, demonstrating high and low affinities. The high-affinity receptor might be down-regulated or desensitized by high concentrations of the ligand. It is conceivable that the CD45RA + T cell population expresses both high and low affinity receptors constitutively, while the CD45RO + T cells bear only a low-affinity receptor until activated by IL-2 stimulation to express the highaffinity receptor. Other explanations for the different sensitivities of the T cell subsets and for the bell-shaped dose-response curve are possible, and characterization of the innate T cell receptors for HSP60 will help clarify the issue.
TLR molecules are thought to constitute "pattern recognition receptors" directed to "pathogen associated molecular patterns" (32, 39 ). Yet, TLR4 (14) and, as we find here, TLR2 are likely to be involved in signaling by self-HSP60. The present results, which relate to T cell behavior in vitro, call attention to the possibility that the innate T cell response to HSP60 might have functional consequences. HSP60 expression is up-regulated during inflammation, and HSP60 has been detected in soluble form in the blood in the nanogram to microgram per milliliter range of concentrations (5, (8) (9) (10) . Thus, soluble HSP60 may modulate the innate arm of the immune system and influence the adaptive autoimmune receptors to HSP60 (40) .
It is interesting that HSP60 seems to interact with diverse receptor molecules, like TLR2 and TLR4. It has also been shown that HSP70, gp96, and HSP90 interact with human macrophages via the CD91 and TLR4 molecules and, thereby, affect cytokine and chemokine secretion by these cells and their antigen presentation capacities (41) (42) (43) (44) . It is conceivable that molecules such as CD91, TLR2, and TLR4 are components of common signaling pathways activated by diverse ligands. The different ligands may bind directly to other molecules that trigger CD91 and the TLR molecules further downstream. Indeed, it appears that HSP60 requires CD14, TLR2, and TLR4 for signaling of macrophages, but HSP60 does not bind directly to these molecules (43, 45) . It is conceivable that HSP60 and other stress protein molecules activate TLR signaling by first forming complexes with other carrier molecules (46) . HSP70 has been reported to produce anti-inflammatory effects in models of endotoxemia (47) , ischemic injury (48), hypoxia (49) , and acute respiratory stress syndrome (50) . HSP60-induced activation of MHC-I-expressing APC was shown to affect the ability of antigen-specific CD8 + T cells to secrete IFNγ in the absence of antigenic peptides (51) . However, although the effect of HSP60 on macrophages is also likely to enhance inflammatory reactions, the present finding that HSP60 can inhibit T cell chemotaxis points to a more subtle influence of HSP60 on inflammation. Based on the present results, low concentrations of HSP60 would be expected to impede the mobilization to an inflammatory site of "high affinity" cells like the "naïve" CD45RA + T cell population. However, low concentrations of HSP60 would not inhibit the chemotaxis of the nonactivated "memory" CD45RO
+ T cell population. Indeed, a high concentration of HSP60 at the inflammatory site might prevent the exit of the CD45RO + T cells from the site by enhancing their adhesion to the ECM. Upon contact with T cell regulatory factors such as IL-2, the CD45RO + T cells would acquire increased sensitivity to HSP60 signals. These possibilities are currently under investigation. + T cells were treated with 0.1 ng/ml HSP60, 100 ng/ml SDF-1α, 100 IU/ml IL-2, 100 ng/ml RANTES, 50 ng/ml PMA, 100 ng/ml VEGF, or 100 ng/ml FGF for 30 min and tested for adhesion to FN. The mean ± SD of 3 independent experiments is shown. + or CD45RO + T cells, unseparated T cells, or PBMC were lysed, and the level of TLR2 and TLR4 expression in the cells was determined by Western blotting using specific mAb against TLR2 and TLR4. The SDS-PAGE profile shows a representative experiment of 3 that produced similar results. B). CD45RA + T cells were pretreated with mAb anti-TLR2 or anti-TLR4 (20 µg/ml). The cells were then treated with HSP60 (0.1 ng/ml), and percent adhesion to FN was determined. The mean ± SD of 4 independent experiments is shown. C) Thymocytes of wild-type C3HeB/FeJ, or TLR4-mutated C3H/HeJ mice (>95% CD45RA + T cells) or thymocytes of Chinese hamsters were radiolabeled, pretreated with HSP60, and seeded onto FNcoated microtiter wells. The mean ± SD of 3 different experiments is shown. D) Anti-TLR2 mAb treatment inhibits HSP60-induced adhesion of CD45RA + T cells but not adhesion induced by SDF-1α or IL-2. The T cells were treated with HSP60 (0.1 ng/ml), SDF-1α (100 ng/ml), or IL-2 (100 IU/ml), and tested for adhesion. Open bars: control mAb. The mean ± SD for 5 different experiments is shown. + (A, C) and CD45RO + (B) T cells were treated (18 h) with 0.1 ng/ml or 1 µg/ml, respectively, of HSP60, washed, and stained with 20 µg/ml mAb anti-CXCR4 (A, B) , anti-CCR7 (C), anti-LFA-1, or L-selectin (D), followed by a secondary FITC-conjugated Ab. Receptor expression was determined by FACScan analysis. One representative experiment of 5 is shown. E) CD45RA + T cells were pretreated (1 h) with mAb anti-TLR2 or anti-TLR4 (20 µg/ml). The cells were then activated with HSP60 (0.1 ng/ml for 18 h), and CXCR4 expression was determined as above. The results are shown as the average of mean fluorescence ± SD of 3 experiments.
